HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kidney transplant in Gitelman's syndrome. Report of the first case.

Abstract
This paper is the first report of a patient with Gitelman's syndrome who, after developing a chronic nephropathy leading to end-stage renal disease, underwent kidney transplantation. The clinical findings of this disease, which include hypokalemia, high angiotensin II and aldosterone levels, sustained hyporesponsiveness to the pressor action of angiotensin II and norepinephrine, normo/hypotension and hypovolemia; the clinical course after kidney transplantation highlights the importance and the need for carefully controlling the hemodynamic status of these patients. In fact, the persistence of normo/hypotension and hypokalemia, in the presence of increased levels of Ang II and aldosterone to which the transplanted kidney should normally respond, raises interesting questions about the mechanisms responsible for the regulation of patient's vascular tone and potassium homeostasis after transplantation, which could expose the patient to post-transplant hypoperfusive renal failure and its long-term complications.
AuthorsLorenzo A Calò, Francesco Marchini, Paul A Davis, Paolo Rigotti, Elisa Pagnin, Andrea Semplicini
JournalJournal of nephrology (J Nephrol) 2003 Jan-Feb Vol. 16 Issue 1 Pg. 144-7 ISSN: 1121-8428 [Print] Italy
PMID12649546 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Bartter Syndrome (complications, diagnosis)
  • Female
  • Follow-Up Studies
  • Hearing Loss, Sensorineural (complications, diagnosis)
  • Humans
  • Kidney Failure, Chronic (complications, diagnosis, surgery)
  • Kidney Transplantation (adverse effects, methods)
  • Postoperative Complications (therapy)
  • Postoperative Period
  • Rare Diseases
  • Risk Assessment
  • Syndrome
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: